Welcome to the e-CCO Library!

P779: Clinical outcome with biological therapy in ulcerative colitis: Real-world clinical setting from a multi-centre observational study
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Ramos1*, A. Hernandez Camba1, R. De La Barreda1, M. Vela2, I. Alonso-Abreu1, R. Gloria Esther2, M. Carrillo-Palau1, C. Tardillo2, Y. Rodríguez2, A. Figueroa Marrero3, D. Ceballos3, N. Cruz4, L. Kolle Casso5, A. Jiménez6, E. Quintero Carrión1,7

Created: Thursday, 21 February 2019, 9:14 AM
P779: COMPARATIVE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB VS ANTI-TNFs IN ULCERATIVE COLITIS BIO-NAÏVE PATIENTS AND PATIENTS WITH FAILURE OF ONE PREVIOUS ANTI-TNFα (EVOLVE-IBERIA STUDY)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Casellas Jorda, F.(1)*;Rodríguez, C.(2);Gisbert, J.P.(3);Bernardo, S.(4);Aparicio, J.(5);Tagarro, I.(5);Muñoz, F.(6);
Created: Friday, 14 July 2023, 11:12 AM
P779: Extra intestinal manifestations and other comorbidities in Crohn’s disease and Ulcerative colitis are equally likely to appear before IBD diagnosis: a Danish nationwide registry study from 2003 to 2015
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Vadstrup*1, S. Alulis1, A. Borsi2, T. R. Jørgensen3, A. Nielsen4, P. Munkholm5, N. Qvist6

Created: Friday, 22 February 2019, 9:41 AM
P780 Proteinuria is associated with the development of Crohn’s disease: a nationwide population-based study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.S. Kim, S. Park, H.J. Lee, H. Soh, J.M. Moon, S.W. Hong, E.A. Kang, J.P. Im

Created: Thursday, 30 January 2020, 10:12 AM
P780: 3-oxo-C12:2-HSL, a new N-acyl-homoserine lactone identified in gut ecosystem exerts an anti-inflammatory effect and does not modify paracellular permeability
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Le Balc'h E.*1, Landman C.1, Tauziet E.1, Brot L.1, Quevrain E.1, Rainteau D.1, Grill J.-P.1, Thenet S.2, Seksik P.1

Created: Wednesday, 20 February 2019, 10:36 AM
P780: Interchangeability by a biosimilar of infliximab: What do patients think?
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Baudrant1*, A. Roche1, B. Allenet1, L. Grange2, L. Bouillet3, N. Mathieu4, B. Bonaz4

Created: Thursday, 21 February 2019, 9:14 AM
P780: Medical treatment and surgery in patients with elderly-onset inflammatory bowel disease: 3-year follow-up of Epi-IBD 2010–2011 cohorts
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

V. Hernandez*1, J. Martinez-Cadilla1, E. Langholz2, D. Christodoulou3, S. Turcan4, D. Valpiani5, P. L. Lakatos6, Z. Vegh6, A. Goldis7, E. Belousova8, K. Ladefoged9, G. Kiudelis10, D. McNamara11, O. Shonova12, Z. Krznarić13, F. Magro14, E. S. Bjornsson15, S. Almer16, M. Fumery17, D. Duricova18, A. Kievit19, I. Kaimakliotis20, P. Ellul21, O. Niewiadomski22, M. Giannotta23, S. Odes24, N. Pedersen25, J. F. Dahlerup26, J. F. Dahlerup26, R. Salupere27, R. D'Incà28, R. D'Incà28, J. Halfvarson29, P. Oksanen30, N. Arebi31, K. R. Nielsen32, V. Andersen33, S. Shaji34, P. Munkholm35, J. Burisch35, Epi-IBD-group1

Created: Friday, 22 February 2019, 9:41 AM
P780: Prognosis and optimal treatment for 5-aminosalicylic acid-intolerant patients with Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Yaguchi, K.(1,2)*;Kinoshita, H.(1);Kunisaki, R.(1,2);Madarame, A.(1);Tatsuno, M.(1);Nishikawa, Y.(1);Hama, T.(1);Onishi, M.(1);Kobayashi, K.(1);Shibui, S.(1);Toritani, K.(1);Nishida, D.(1);Matsubayashi, M.(1);Nakamori, Y.(1);Nishio, M.(1);Umezawa, S.(1);Ogashiwa, T.(1);Sasaki, T.(1);Fujii, A.(1);Kimura, H.(1);Kato, J.(3);Maeda, S.(2);
Created: Friday, 14 July 2023, 11:12 AM
P781 Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M.J. García García, J.C. Rodriguez-Duque, M.T. Arias Loste, B. Castro Senosiain, J. Crespo, M. Rivero

Created: Thursday, 30 January 2020, 10:12 AM
P781: Biological treatment and surgery in IBD patients stratified by age groups
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Svatun Lirhus1*, M. Ekmark2, B. Saeboe2, B. Moum3, H.O. Melberg4,5

Created: Thursday, 21 February 2019, 9:14 AM
P781: Defining the economic burden of venous thromboembolism after surgery for inflammatory bowel disease in the USA: a national inpatient sample study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. H. A. Lee1, A. Aiello2, L. Stocchi1, J. Lipman1, S. Shawki1, T. Hull1, S. Steele1, S. Holubar*1

Created: Friday, 22 February 2019, 9:41 AM
P781: The stability of the fecal microbiota in Crohn's disease patients with changing disease course
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Tedjo D.1,2, Savelkoul P.2, Masclee A.1, Bodelier A.1, Pierik M.1, Penders J.2, Jonkers D.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P781: Treatment outcome of tofacitinib dose reduction to 5 mg BID vs remaining on 10 mg BID in patients with Ulcerative Colitis who were in stable remission on 10 mg BID: Updated 30-month data from the double-blind, randomised RIVETING study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Rubin, D.T.(1);Panés, J.(2);Torres, J.(3,4,5);Kobayashi, T.(6);Su, C.(7);Lawendy, N.(7);Modesto, I.(8);Segovia, M.(7,9);Gardiner, S.(8);Wang, W.(7);Vermeire, S.(10)*;
Created: Friday, 14 July 2023, 11:12 AM
P782 Immune status to viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H.S. Hong1, J. Jung2, S.H. Park3, S.M. Noh4, E.H. Oh4, J.Y. Kim4, J. Kim4, S.W. Hwang3, D.H. Yang4, J.S. Byeon4, S.J. Myung4, S.K. Yang3, B.D. Ye3

Created: Thursday, 30 January 2020, 10:12 AM
P782: A new compatibility test for donor selection for faecal microbiota transplantation in ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ponce-Alonso M.1, Garcia-Fernandez S.1, Aguilera L.2, Rodriguez-de-Santiago E.2, Foruny J.R.2, Roy G.3, DelCampo R.1, Canton R.1, Lopez-Sanroman A.*2

Created: Wednesday, 20 February 2019, 10:36 AM
P782: Living with ulcerative colitis in Germany: quantifying the healthcare resource utilisation and direct healthcare costs associated with the treatment of moderate to severe ulcerative colitis in Germany
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Dignass*1, J. Waller2, J. C. Cappelleri3, L. Salese4, A. Kisser5, L. Dietz5, M. DiBonaventura6, R. Wood2, D. Bargo6

Created: Friday, 22 February 2019, 9:41 AM
P782: Natural history of acute severe ulcerative colitis in elderly: A population-based study
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Bril1*, A. Leroyer2, M. Fumery3, C. Charpentier1, B. Pariente2, H. Sarter2, D. Laharie4, C. Gower-rousseau2, G. Savoye1

Created: Thursday, 21 February 2019, 9:14 AM
P782: Ustekinumab in Ulcerative colitis: a real-life effectiveness study across multiple Belgian centers (SULTAN)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Holvoet, T.(1)*;Truyens, M.(2);Reenaers, C.(3);Baert, F.(4);Vandenbranden, S.(5);Cremer, A.(6);Pouillon, L.(7);Dewint, P.(8);Van Moerkercke, W.(9);Rahier, J.F.(10);Vandermeulen, L.(11);Van Dongen, J.(12);Peeters, H.(13);Lambrecht, G.(14);Vijverman, A.(15);Lobaton, T.(16);
Created: Friday, 14 July 2023, 11:12 AM
P783 Non-alcoholic fatty liver disease and advanced liver disease in patients with inflammatory bowel disease: prevalence and risk factors
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Demir

Created: Thursday, 30 January 2020, 10:12 AM
P783: Ciprofloxacin resistance in ESBL producing enterobacteriaceae colonizing the gut in IBD patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Skuja V.*1,2, Pekarska K.3, Straume Z.2,4, Rudzīte D.5, Lavrinoviča E.5, Piekuse L.6, Dauvarte H.3, Vašuka E.1,7, Dobelniece L.1,7, Zalizko P.4,8, Derovs A.2,9, Krūmiņa A.10,11, Lejnieks A.1,7

Created: Wednesday, 20 February 2019, 10:36 AM